That Marketing Solution, Inc. (TSTS)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
That Marketing Solution, Inc. (TSTS) trades at $0.00. That Marketing Solution, Inc. is a development stage company focused on nutritional products, specifically Low-T capsules, an over-the-counter supplement targeting decreased testosterone levels in men. Market cap: $12,754, Sector: Healthcare.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for TSTS: TSTS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates TSTS against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
TSTS: 1/1 perspectives are bearish.
How is this calculated? →That Marketing Solution, Inc. (TSTS) Healthcare & Pipeline Overview
That Marketing Solution, Inc. is a development-stage company in the healthcare sector, focusing on the development, manufacturing, and marketing of nutritional supplements, primarily Low-T capsules. These capsules target decreased testosterone levels in men over 30, offering a natural, over-the-counter solution in a competitive market.
What Is the Investment Thesis for TSTS?
That Marketing Solution, Inc. presents a high-risk, high-reward investment opportunity given its development stage and focus on a single product. The potential success of Low-T capsules hinges on effective marketing and consumer adoption in a competitive market. Key value drivers include successful product launch, positive consumer reviews, and expansion of distribution channels. The company's financial performance is currently characterized by negative profit and gross margins (-159019.4% and -4125.5%, respectively), reflecting its development stage. A successful market entry could lead to significant revenue growth, but the company's small size and limited resources pose substantial risks. Investors should closely monitor the company's progress in securing funding, establishing manufacturing capabilities, and executing its marketing strategy. The high beta of 8.85 indicates significant volatility.
Based on FMP financials and quantitative analysis
TSTS Key Highlights
- Market capitalization of 13K, reflecting its development stage and limited operations.
- Negative P/E ratio of -0.00, indicative of current losses and lack of profitability.
- Profit margin of -159019.4%, highlighting the significant expenses relative to revenue.
- Gross margin of -4125.5%, showing the high cost of goods sold compared to revenue.
- Beta of 8.85, indicating high volatility compared to the market.
Who Are TSTS's Competitors?
TSTS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| LGND Ligand Pharmaceuticals Incorporated | $318.27 | -0.40% | $6.38B | 99 |
| ATAI Atai Beckley NV is a clinical-stage biopharmaceutical company focused on developing treatments for mental health disorders. The company | $4.88 | -5.97% | $1.80B | 68 |
| MEDS TRxADE HEALTH, Inc. | $7.59 | +4.55% | $13.28M | 63 |
| ONC BeOne Medicines Ltd. | $309.46 | +3.97% | $33.07B | 61 |
| NEUP Neuphoria Therapeutics Inc. | $3.44 | +1.78% | $18.59M | 60 |
| YI 111, Inc. | $4.13 | -0.12% | $36.04M | 44 |
| ALBHF Alibaba Health Information Technology Limited | $0.42 | +2.44% | $6.77B | 45 |
| WBA Walgreens Boots Alliance operates as a pharmacy-led health and beauty retail company with a global presence. The company | $11.98 | +0.50% | $10.37B | 45 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are TSTS's Key Strengths?
- Proprietary formula for Low-T capsules.
- Focus on a specific niche market.
- Potential for direct-to-consumer sales.
What Are TSTS's Weaknesses?
- Development stage company with limited resources.
- Reliance on a single product.
- Negative profit and gross margins.
What Could Drive TSTS Stock Higher?
- Launch of initial marketing campaigns for Low-T capsules (Q2 2026).
- Securing partnerships with online retailers for product distribution (Q3 2026).
- Development of new nutritional supplement formulas to expand product line.
- Efforts to increase brand awareness and customer acquisition through digital marketing.
What Are the Key Risks for TSTS?
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Intense competition from established companies in the nutritional supplement market.
- Regulatory scrutiny and potential changes in regulations governing nutritional supplements.
- Limited financial resources and potential need for additional funding.
- Dependence on a single product (Low-T capsules).
- Low liquidity of the stock due to trading on the OTC market.
What Are the Growth Opportunities for TSTS?
- Expansion of Product Line: Developing and introducing new nutritional supplements targeting other health concerns could significantly increase revenue streams. The market for dietary supplements is projected to reach $286.7 billion by 2028, offering ample opportunity for growth. This expansion would require additional investment in research and development, as well as marketing to reach new customer segments. Timeline: 2-3 years.
- Strategic Partnerships: Collaborating with established retailers or distributors could provide access to a wider customer base and improve market penetration. Forming partnerships with major pharmacies or online retailers could accelerate sales growth. The global e-commerce market is expected to reach $7.4 trillion in 2025, making online distribution a critical component of any growth strategy. Timeline: 1-2 years.
- Targeted Marketing Campaigns: Implementing focused marketing campaigns targeting specific demographics and health concerns can improve brand awareness and drive sales. Utilizing digital marketing channels, such as social media and search engine optimization, can reach a large audience at a relatively low cost. The digital advertising market is projected to reach $627 billion in 2024, highlighting the importance of effective online marketing. Timeline: Ongoing.
- Geographic Expansion: Expanding sales and marketing efforts to new geographic markets, both domestically and internationally, can increase revenue potential. Identifying regions with a high demand for testosterone-boosting supplements and establishing distribution networks in those areas could drive growth. The global market for dietary supplements is expected to grow significantly in Asia-Pacific, presenting a potential opportunity for expansion. Timeline: 3-5 years.
- E-commerce Optimization: Enhancing the company's online presence and e-commerce capabilities can improve customer engagement and drive online sales. Investing in a user-friendly website, optimizing product listings, and providing excellent customer service can attract and retain online customers. Online retail sales are projected to reach $6.9 trillion in 2024, making e-commerce a critical channel for growth. Timeline: 1 year.
What Opportunities Does TSTS Have?
- Expansion of product line.
- Strategic partnerships with retailers and distributors.
- Geographic expansion.
What Threats Does TSTS Face?
- Intense competition from established companies.
- Regulatory scrutiny of nutritional supplements.
- Changing consumer preferences.
What Are TSTS's Competitive Advantages?
- Proprietary formula for Low-T capsules.
- Focus on a specific niche market (testosterone-boosting supplements).
- Potential for brand recognition and customer loyalty in the niche market.
What Does TSTS Do?
That Marketing Solution, Inc., founded in 2012 and based in Salt Lake City, Utah, operates as a development stage company within the healthcare sector. The company focuses on the development, manufacturing, advertising, sale, and marketing of nutritional products. Its primary product is Low-T capsules, a proprietary formula blend of nutritional supplements designed to address decreased testosterone levels in males over the age of 30. These capsules are intended to be a natural, non-FDA regulated, and over-the-counter supplement. The company's history includes a name change from Vista Holding Group, Corp. to That Marketing Solution, Inc. in September 2014. Currently, the company is in the development phase, focusing on establishing its presence in the nutritional supplement market. With a small team of two employees, the company is working to bring its Low-T capsules to market. The company's strategy revolves around marketing a non-regulated supplement directly to consumers seeking natural solutions for age-related testosterone decline. The company faces competition from established pharmaceutical and nutraceutical companies, requiring a focused and effective marketing approach to gain market share.
What Products and Services Does TSTS Offer?
- Develop nutritional products
- Manufacture nutritional supplements
- Advertise nutritional products
- Sell nutritional products
- Market nutritional products
- Focus on Low-T capsules, a blend of nutritional supplements
How Does TSTS Make Money?
- Develop and acquire proprietary formulas for nutritional supplements.
- Manufacture supplements or outsource manufacturing.
- Market and sell supplements directly to consumers or through distributors.
What Industry Does TSTS Operate In?
That Marketing Solution, Inc. operates within the competitive nutritional supplement industry, specifically targeting the market for testosterone-boosting products. This market is driven by an aging male population seeking to mitigate the effects of declining testosterone levels. The industry includes both pharmaceutical companies offering prescription testosterone replacement therapies and nutraceutical companies providing over-the-counter supplements. The market is characterized by intense competition, evolving consumer preferences, and regulatory scrutiny. Companies like ACUS, EMYSF, IRBS, LGND, and NEPTF also operate in the broader healthcare and pharmaceutical space, offering a range of products and services. Success in this market requires effective marketing, product differentiation, and adherence to quality standards.
Who Are TSTS's Key Customers?
- Males over the age of 30 experiencing decreased testosterone levels.
- Individuals seeking natural, over-the-counter solutions for health concerns.
- Consumers interested in nutritional supplements and wellness products.
Company Profile
That Marketing Solution, Inc. operates in the Medical - Pharmaceuticals industry within the Healthcare sector. It is headquartered in Salt Lake City, US. The company is led by CEO Darren J. Lopez. TSTS has traded publicly since 2014.
That Marketing Solution, Inc. (TSTS) Valuation Context
Valued at 13K, TSTS is classified as a micro-cap stock.
ROE 232%Key Financial Metrics
Return on equity for That Marketing Solution, Inc. stands at 231.6%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.15 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 3/9Financial Health
That Marketing Solution, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
TSTS Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Proprietary formula for Low-T capsules.
- Focus on a specific niche market.
- Potential for direct-to-consumer sales.
- Upcoming: Launch of initial marketing campaigns for Low-T capsules (Q2 2026).
Bear Case
- Development stage company with limited resources.
- Reliance on a single product.
- Negative profit and gross margins.
- Potential: Intense competition from established companies in the nutritional supplement market.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
TSTS Latest News
No recent news available for TSTS.
TSTS Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for TSTS.
Price Targets
Wall Street price target analysis for TSTS.
TSTS MoonshotScore
What does this score mean?
The MoonshotScore rates TSTS's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Darren J. Lopez
CEO
Darren J. Lopez is the CEO of That Marketing Solution, Inc. His background includes experience in managing small teams and overseeing the development and marketing of nutritional products. He has been instrumental in guiding the company through its development stage, focusing on securing the rights to the Low-T capsule formula and establishing the company's initial marketing strategy. His leadership is focused on building a brand presence and driving sales in the competitive nutritional supplement market.
Track Record: Under Darren J. Lopez's leadership, That Marketing Solution, Inc. has acquired the rights to the Low-T capsule formula and initiated its development and marketing efforts. He has focused on building a direct-to-consumer sales model and establishing partnerships with key distributors. The company is currently in the early stages of commercializing its product, and its success will depend on his ability to execute the company's growth strategy.
TSTS OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that That Marketing Solution, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk and greater potential for volatility compared to exchange-listed stocks.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and transparency.
- Low liquidity and high bid-ask spreads.
- Potential for price manipulation and volatility.
- Higher risk of fraud or mismanagement compared to exchange-listed companies.
- Limited regulatory oversight and investor protection.
- Verify the company's legal status and registration.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Check for any regulatory actions or legal disputes.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Company registration and good standing with regulatory authorities.
- Availability of some financial information, even if limited.
- A clear business plan and market strategy.
- Active communication with investors and stakeholders.
- Positive customer reviews or testimonials (if available).
TSTS Healthcare Stock FAQ
What does That Marketing Solution, Inc. do?
That Marketing Solution, Inc. is a development stage company focused on the development, manufacturing, advertising, sale, and marketing of nutritional products. Its primary product is Low-T capsules, a proprietary formula blend of nutritional supplements designed to address decreased testosterone levels in males over the age of 30. The company aims to provide a natural, over-the-counter solution to consumers seeking to manage age-related testosterone decline. The company is currently focused on establishing its presence in the competitive nutritional supplement market.
What do analysts say about TSTS stock?
As of March 17, 2026, there is no available analyst coverage for That Marketing Solution, Inc. due to its development stage and OTC listing. Key valuation metrics such as P/E ratio (-0.00) and profit margin (-159019.4%) reflect the company's current losses and lack of profitability. Investors should conduct their own due diligence and consider the company's growth potential, risks, and financial condition before making any investment decisions. The company's success hinges on the successful commercialization of Low-T capsules and its ability to expand its product line and market reach.
What are the main risks for TSTS?
The main risks for That Marketing Solution, Inc. include intense competition from established companies in the nutritional supplement market, potential regulatory scrutiny of its products, and its dependence on a single product (Low-T capsules). The company's limited financial resources and development stage also pose significant risks. Additionally, the stock's low liquidity due to trading on the OTC market increases the risk of price volatility and difficulty in executing trades. Investors should carefully consider these risks before investing in TSTS.
What are the key growth opportunities for TSTS in healthcare?
That Marketing Solution, Inc.'s key growth opportunities lie in expanding its product line beyond Low-T capsules to address other health concerns, forming strategic partnerships with established retailers and distributors to increase market reach, and expanding its geographic presence both domestically and internationally. The company can also leverage digital marketing channels to increase brand awareness and drive online sales. Successful execution of these strategies could significantly increase revenue and market share in the competitive healthcare and nutritional supplement market.
How does That Marketing Solution, Inc. navigate regulatory approval processes?
That Marketing Solution, Inc. focuses on developing and marketing nutritional supplements that are intended to be non-FDA regulated and over-the-counter. This strategy allows the company to avoid the lengthy and costly FDA approval process required for pharmaceuticals. However, the company must still comply with regulations governing the labeling, manufacturing, and marketing of dietary supplements. The company's success depends on maintaining compliance with these regulations and avoiding any claims that would require FDA approval. Investors should monitor the company's compliance efforts and any potential regulatory challenges.
What are the key factors to evaluate for TSTS?
Evaluate TSTS on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does TSTS data refresh on this page?
TSTS prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven TSTS's recent stock price performance?
That Marketing Solution, Inc. (TSTS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary formula for Low-T capsules. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available due to the company's development stage and OTC listing.
- Financial data is based on available information and may not be comprehensive.